Not Yet RecruitingNot Applicable

Comparing Music-Supported and Traditional Aerobic Training in Geriatric Health Outcomes

33 participantsStarted 2025-06-01

Plain-language summary

The aim of this study is to comparatively evaluate the effects of a music therapy-based aerobic exercise program and traditional aerobic exercise training on cardiopulmonary functions, functional capacity, balance, peripheral muscle strength, cognitive functions, depression level and quality of life in geriatric individuals.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being 65 years of age or older * Willingness to participate in the study Exclusion Criteria: * Presence of uncontrolled hypertension (≥180/110 mmHg) or severe complications of diabetes (e.g., diabetic neuropathy, proliferative retinopathy, uncontrolled hypoglycemic episodes) * Presence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, etc. * Presence of chronic neurological disorders such as Multiple Sclerosis (MS), Parkinson's Disease, Amyotrophic Lateral Sclerosis (ALS), etc. * Diagnosis of any oncological disease * Presence of acute musculoskeletal conditions that would prevent participation in exercise (e.g., fracture, advanced osteoarthritis, severe musculoskeletal injuries) * Having undergone any surgical operation within the past 6 months * Presence of visual or auditory impairments that could interfere with the assessment procedures * A score of ≤24 on the Mini-Mental State Examination (MMSE), indicating cognitive impairment * Participation in a regular exercise program within the last six months

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Heart Rate (beats per minute)

Timeframe: 2 months

Heart Rate Recovery (beats per minute)

Timeframe: 2 months

Blood Pressure (mmHg)

Timeframe: 2 months

Modified Borg Scale Score

Timeframe: 2 months

Forced Expiratory Volume in 1 Second (FEV1) (% predicted)

Timeframe: 3 months

Forced Vital Capacity (FVC) (% predicted)

Timeframe: 3 months

FEV1/FVC Ratio

Timeframe: 3 months

Peak Expiratory Flow (PEF) (% predicted)

Timeframe: 3 months

Trial details

NCT IDNCT06980311

SponsorBezmialem Vakif University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06-01

Contact for this trial

Alis Kostanoğlu, PhD

+905434931848 aliskostanoglu@gmail.com

View on ClinicalTrials.gov More Geriatric trials

Plain-language summary

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Heart Rate (beats per minute)

Timeframe: 2 months

Heart Rate Recovery (beats per minute)

Timeframe: 2 months

Blood Pressure (mmHg)

Timeframe: 2 months

Modified Borg Scale Score

Timeframe: 2 months

Forced Expiratory Volume in 1 Second (FEV1) (% predicted)

Timeframe: 3 months

Forced Vital Capacity (FVC) (% predicted)

Timeframe: 3 months

FEV1/FVC Ratio

Timeframe: 3 months

Peak Expiratory Flow (PEF) (% predicted)

Timeframe: 3 months